Loading...
  • protein
  • This study will evaluate the safety of a rectally administered product, EMP-123, consisting of three recombinant modified peanut protein antigens encapsulated within dead E. coli. (clinicaltrials.gov)
  • allergies
  • As of November 2009, this study is no longer recruiting healthy volunteers and will only be recruiting individuals with peanut allergies. (clinicaltrials.gov)
  • baseline
  • The investigators are proposing a cross-over trial with 85 peanut-allergic adults who will each undergoing a baseline peanut challenge followed by repeat challenges with extrinsic factors applied, in random order (repeat baseline, +exercise and +sleep restriction). (clinicaltrials.gov)
  • Based on the baseline oral food challenge, the participants will be advised to begin introducing peanut following the current practice guidelines. (clinicaltrials.gov)
  • serum
  • Serum Total IgE and peanut-specific IgE will be measured for assessment of atopy in general and confirmation of Peanut allergy respectively. (clinicaltrials.gov)
  • Specific IgE to peanut, analyzed from the serum sample sent days earlier for measurement of specific IgE to salmon, was found to be detectable at 1.05 kU/L on fluoroenzyme immunoassay. (cmaj.ca)